Lobbying Filing Details

Total Spending

$200,000

Activities

1

Lobbyists

1

Gov't Entities

2

Filing Information
Filing UUID:
081881eb-8c4a-4282-b0be-558573ffe674
Type:
Q1 - 1st Quarter - Report
Period:
2021 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2021 at 8:56 PM
Income:
$0
Expenses:
$200,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Melissa Banashak
Registrant
INCYTE CORPORATION

Biopharmaceutical Company

Wilmington, Delaware
Client
INCYTE CORPORATION
Delaware, United States of America
Lobbying Activities (1)
Activity 1
Medicare/Medicaid

Issues related to 340B (contract pharmacy provisions); Issues relating to Medicare Part D Pricing Reform; Issues relating to Medicare Part B pricing reform; Issues related to Part B refunds for discarded amounts of certain single-dose container or single-use package drugs.

Lobbyists (1)
  • MS. MELISSA WIER BANASHAK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 19, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.